Au-Ag-Cu2O NG With PTT Anti Drug-resistant Microbial Keratitis
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
This clinical study was conducted to evaluate the efficacy and safety of gold-silver cuprous
oxide composite nanogels combined with photothermal therapy system in the treatment of severe
drug-resistant bacterial keratitis ineffective by traditional antibiotic treatment in human
eyes, and to provide translational applications. Based on the clinical evidence, a more
effective and safe innovative treatment plan for corneal diseases has been developed.
Phase:
Early Phase 1
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University